Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and olanzapine factorial trial in on-pump cardiac surgery
2021-005618-32Phase 3Active
- Sponsor
- Rigshospitalet
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of HiDex and olanzapine in coronary arteriosclerosis and Cardiac valve disease (VHD) (4 arms), sponsored by Rigshospitalet. Started Nov 2021; status: active.
02
Drugs
HiDexolanzapine
03
Conditions
coronary arteriosclerosisCardiac valve disease (VHD)
Beyond the preview
Go deeper on 2021-005618-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005618-32.